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Abstract
Background—There is interest in assessing healthcare utilization and expenditures among new
Medicaid enrollees after the 2014 Medicaid expansion. Recent studies have not differentiated
between newly enrolled individuals and those returning after coverage gaps.
Objectives—To assess healthcare expenditures among Medicaid enrollees in the 24 months after
Oregon’s 2014 Medicaid expansions and examine whether expenditure patterns were different
among the newly, returning, and continuously insured.
Research Design—Retrospective cohort study using inverse-propensity weights to adjust for
differences between groups.
Subjects—Oregon adult Medicaid beneficiaries insured continuously from 2014-2015 who were
either newly, returning, or continuously insured.
Measures—Monthly expenditures for inpatient care, prescription drugs, total outpatient care,
and subdivisions of outpatient care: emergency department (ED), dental, mental and behavioral
health (MBH), primary care (PC), and specialist care.
Results—After initial increases, newly and returning insured outpatient expenditures dropped
below continuously insured. Expenditures for ED and dental services among the returning insured
remained higher than among the newly insured. Newly insured MBH, PC, and specialist
expenditures plateaued higher than returning insured. Prescription drug expenditures increased
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over time for all groups, with continuously insured highest and returning insured lowest. All
groups had similar inpatient expenditures over 24 months post-Medicaid expansion.
Conclusions—Our findings reveal that outpatient expenditures for new non-pregnant, non-dualeligible Oregon Medicaid recipients stabilized over time after meeting pent-up demand, and prior
insurance history affected the mix of services that individuals received. Policy evaluations should
consider expenditures over at least 24 months and should account for enrollees’ prior insurance
histories.
Keywords
Health insurance; Medicaid; medical expenditures; policy evaluation

INTRODUCTION
The Affordable Care Act (ACA) led to historic expansions in Medicaid to cover nondisabled adults with incomes up to 138% of the poverty line. These 2014 Medicaid
expansions have enhanced healthcare access and reduced disparities in coverage by income,
age, and race/ethnicity.1–2 There has been great interest in assessing healthcare utilization
and expenditures among people who enrolled in Medicaid after the implementation of the
2014 expansions. Expenditures for the Medicaid population after 2014 cannot be predicted
using pre-2014 data because the population gaining coverage in 2014 differed from the
previously enrolled Medicaid population on a number of key characteristics, due to pre-ACA
restrictions that limited eligibility to low-income individuals who were pregnant, parents of
eligible children, or had specific disabilities.3 Thus, research is needed to understand the
healthcare utilization and expenditure patterns of individuals who gained insurance within
this new regulatory context.
A recent study reported a surge in demand for care post-ACA, including increased use of
preventive services at community health centers (CHC).4 Yet, little is known about whether
heightened demand for CHC services occurred in conjunction with demand for other
healthcare services, and whether it represents an initial spike based on pent-up demand that
resolves over time, or whether these enrollees have greater, sustained healthcare needs.
Initial post-ACA studies suggest that newly insured individuals have lower healthcare needs
than those insured continuously,5–6 with a decreasing reliance on emergency care over time5
as well as lower total monthly expenditures.6 These studies, however, were limited to 6 to 12
months of post-expansion data, and while they compare newly and continuously insured
populations, they do not separate individuals who are completely new to Medicaid from
those who have returned after coverage gaps (the ‘returning insured’). Understanding
patterns among the returning insured and differentiating this group from the newly insured is
particularly important given past evidence regarding how transitioning on and off Medicaid
frequently (known as ‘churn’) is associated with higher rates of healthcare utilization.7–8
Oregon is the expansion state that experienced the fourth-highest coverage gain in the first
year, from 14.7% uninsured in 2013 to 9.7% in 2014.9 Oregon Medicaid enrollment jumped
from 614,183 enrollees in 2013 to over a million–a quarter of the state’s population–by the
end of 2015.10 Thus, Oregon is an excellent setting in which to further examine the 2014
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Medicaid expansion and study the effect of insurance gain on a large segment of the state’s
population. To address gaps in current evidence stemming from short study periods and
coarsely-defined insurance groups, we conducted a retrospective cohort study of Medicaidinsured adults who were insured for 24 months after the 2014 Oregon Medicaid expansion.
We modeled monthly inpatient, prescription drug (Rx), total outpatient, and subdivisions of
outpatient [emergency department (ED), dental, mental and behavioral health (MBH),
specialist, and primary care (PC)] Medicaid expenditures over the two years following
insurance gains, aiming to better understand the long-term healthcare utilization patterns of
individuals as a function of their prior coverage histories.

METHODS
Study Population
Our study population included adults aged 19-64 insured by Oregon Medicaid continuously
from January 2014 through December 2015.We obtained Oregon Medicaid enrollment data
(01/01/2002-12/31/2015) and administrative claims (01/01/2014-12/31/2015) from the
Oregon Health Authority that included both fee-for-service and managed care beneficiaries.
We used the enrollment data to create the following insurance groups:
1.

Newly insured patients did not have Medicaid coverage from 2002-2013 and had
continuous coverage in 2014-2015;

2.

Returning insured patients had Medicaid coverage sometime during 2002-2012,
no coverage in 2013, and continuous coverage in 2014-2015;

3.

Continuously insured patients had Medicaid coverage for all of 2013 and
continuous coverage in 2014-2015.

We excluded patients without coverage on 1/1/2014 and those with coverage gaps during the
study period, so that changes in mean monthly expenditures would reflect changes in
utilization among enrolled individuals rather than changes in enrollment. Because we had no
access to Medicare data, we excluded patients with dual Medicaid and Medicare eligibility.
We further excluded patients whose 2014-2015 eligibility did not depend on FPL (e.g.
pregnant women), as coverage for these patients was not related to the Medicaid expansion.
Of 622,513 adults aged 19-64 with any 2014 Medicaid enrollment, 230,602 (37%) remained
in our sample. See Appendix Exhibit 1 for details on exclusions.
Propensity Score Weighting
Because the insurance groups differed on a number of characteristics that affect medical
expenditure, we used inverse-probability of treatment weighting (IPTW) to adjust for
observable differences between groups. Specifically, we implemented a generalized boosted
model that included the patient’s age, sex, racial and ethnic background, rural setting, and
comorbidity level as assessed by the enhanced Charlson comorbidity index11 to generate
weights.12 Average treatment effect (ATE) propensity weights were specified using the
twang13 (toolkit for weighting and analysis of nonequivalent groups) package in R (version
3.4.0). We calculated absolute standardized mean differences (ASMD) between insurance
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groups before and after weighting to assess propensity score performance; standardized
differences of less than 0.10 suggest good balance.
Cost Assignment
Alternative payment methods, implemented in Oregon in 2012 when Medicaid Coordinated
Care Organizations (CCOs) moved from a fee-for-service model to a global budget, are
known to generate ‘shadow claims’ that include diagnosis and procedure information but
record the paid amount as zero; therefore, expenditure estimates based on paid amounts fail
to account for payments made outside of a fee-for-service system.14 Therefore, to ensure
outpatient services were associated with appropriate and consistent costs, we repriced them
by connecting procedure codes with Oregon Medicaid fee schedule amounts.14 We also
created standardized expenditures for inpatient and prescription drug claims. For inpatient,
we multiplied the diagnosis-related group (DRG) weight of a service by a constant to reprice
the claim. Finally, we calculated the 30-day cost associated with each National Drug Code
(NDC). For details on the creation of outpatient, inpatient, and medication standardized
expenditures, see Appendix Exhibit 2.
Statistical Analysis
We used administrative claims to generate the dependent variables: standardized
expenditures for inpatient care, prescription drugs, and total outpatient care in addition to
subdivisions of outpatient: outpatient claims were classified as either ED, dental, MBH, PC
evaluation, management, and procedures (EM+P), specialist EM+P, and PC/specialist
imaging or tests based on a hierarchical system involving procedure code, provider type,
provider specialty, place of service, and associated costs (Appendix Exhibit 3).
The primary independent variables were insurance group, time, and their interaction terms.
We summarized enrollee utilization outcomes as mean monthly expenditures, running a
separate hurdle model for each type. A hurdle is a type of two-part model often used by
economists because it addresses zero values in the data incompatible with an assumed
continuous distribution of costs.15 In hurdle models, a) the probability of a positive value
and b) the actual value, given that it is positive, are assumed to be governed by separate
processes. Under the assumption that non-zero values occur once a threshold for any
utilization is crossed, a) and b) are combined to yield more accurate predictions of expected
costs.
We generated all monthly expenditure estimates and standard errors with churdle, an
implementation of Cragg’s exponential hurdle16 in Stata 14.2, using restricted cubic
splines17 to capture the differential variation in expenditures over time by insurance cohort.
We report 95% confidence intervals on all unadjusted and covariate-adjusted estimates
(Appendix Exhibits 4–5).
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RESULTS
Covariate Balance
Prior to weighting, the insurance groups differed on multiple demographic characteristics
(Table 1). The newly insured (NI) were more likely to be older, male, Hispanic, live in a
non-rural location, and have fewer co-morbidities. The returning insured (RI) and
continuously insured (CI) were more likely to be younger, female, non-Hispanic white, live
in a rural location, and have more comorbidities, with many of these differences especially
marked for the continuously insured. Balance improved for all covariates and the effective
sample sizes (ESS, the approximate number of observations under simple random sampling
that would produce variation equivalent to the weighted sample) after weighting were as
follows: 37,821 for the CI, 49,009 for the RI, and 91,951 for the NI, for a total ESS of
178,782.
Outpatient
Outpatient expenditures for NI and RI rise rapidly over the first seven months. Unadjusted
estimates for NI and RI peak in July 2014 at $106 and $122, never reaching the monthly CI
average of $139. Adjusted NI and RI estimates trend together, briefly reaching CI estimates
before leveling off 15% lower (Figure 1).
Inpatient
Inpatient RI and NI expenditures also rise over the first seven months, though not as sharply.
Unadjusted estimates then fluctuate between $50-$57 for RI and $46-$51 for NI, while CI
estimates decline from $63 to $57. In the adjusted model, RI and CI levels are comparable,
while NI estimates trend slightly higher, though not always significantly so (Figure 1).
Emergency
Emergency expenditures for RI and NI surge in the first half of 2014, then decline. In the
unadjusted model, NI and RI peak at $14 and $21 before plateauing around $11 and $18,
while CI estimates hover around $22. In the adjusted model, RI surpasses CI in mid-2014
before falling to a comparable level, with NI substantially lower throughout (Figure 2).
Dental
RI and NI dental expenditures increase during the first half of 2014, then steadily decline. RI
peaks above CI at $11 in both adjusted and unadjusted models, which show similar trends.
By late 2015, RI and CI have similar adjusted estimates, with NI about 15% lower. (Figure
2).
Mental and Behavioral Health (MBH)
RI and NI MBH expenditures increase sharply in the first half of 2014. After plateauing,
unadjusted expenditures average $10 for NI and $13 for RI compared to $18 for CI.
Adjusted NI and RI estimates are similar throughout, significantly lower than CI estimates
(Figure 2).
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Specialist Care: Evaluation, Management and Procedures
Specialist EM + P expenditures for RI and NI more than double over the first half of 2014.
In the unadjusted model, NI and RI levels peak at $31 and $33, never reaching the $38 CI
monthly average. In the adjusted model, RI catches up to and NI surpasses CI for several
months in the latter half of 2014. RI, NI and CI adjusted expenditures all steadily decrease in
late 2015, with CI and NI estimates higher than RI (Figure 3).
Primary Care: Evaluation, Management and Procedures
RI and NI primary care expenditures rise in the first half of 2014 before leveling off. In the
unadjusted model, NI and RI levels peak at $16 and $17, never reaching the $20 CI monthly
average. In the adjusted model, NI catches up to CI briefly before decreasing below, with RI
less than NI. (Figure 3).
PC + Specialist Imaging—Imaging expenditures for RI and NI increase sharply in the
first half of 2014 before leveling off. In the unadjusted model, NI and RI levels peak at $22
and $24, never reaching the $26 CI monthly average. In the adjusted model, NI and RI trend
together, catching up to CI before decreasing to a level below. (Figure 3).
PC + Specialist Tests—RI and NI test expenditures rise at the start of 2014. Though in
the unadjusted model they never quite reach CI levels of $7-$8, in the adjusted model they
do, with NI peaking above the others in mid-2014 before all three groups plateau (Figure 3).
Prescription Drugs—Expenditures increase for all three groups throughout, though at a
lower rate in 2015 than 2014. Unadjusted expenditures for CI increase from $101 to $116,
RI from $22 to $69, and NI from $17 to $69, with RI and NI consistently about $50 less than
CI. Adjusted, NI surpasses RI but never reaches CI, staying 20% different from RI and 25%
from CI (Figure 4).

DISCUSSION
Our findings confirm and greatly expand on those from a smaller, lottery-based expansion of
Medicaid in Oregon in 2008, known as the Oregon Health Insurance Experiment (OHIE),
which showed differing effects over time across a variety of healthcare settings for the newly
insured, returning insured, and continuously insured.7,18 Our studies examine the effects of
expansion in the presence of an insurance mandate, while the OHIE expansion was limited
to individuals who were motivated to register for the possibility of obtaining coverage. We
complement these analyses of the OHIE expansion by looking at a longer time period,
including a greater range of services (dental, inpatient, and prescription drugs), and focusing
on monthly expenditures rather than visit rates.
Confirming findings from the OHIE cohort, returning and newly insured individuals in the
2014 expansion population differed from each other substantially in their adjusted ED
utilization. Expenditures for both groups jumped initially, but returning insured plateaued at
a level comparable to continuously insured, while newly insured estimates were typically
about 20% less. Dental expenditures showed similar patterns, with an initial surge followed
by returning and continuously insured trending together as newly insured leveled off lower.
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Oregon Medicaid does not offer comprehensive dental coverage but does cover urgent
treatment, which may explain similar patterns for ED and dental care. Our weighting
controlled for higher levels of comorbidity among the returning insured relative to the newly
insured; however, persistently higher ED and dental expenditures suggest that individuals
with Medicaid ‘churn’ in their histories may be more likely to suffer complications from
chronic diseases. Their higher medical and social complexity may have led to issues with
maintaining coverage in the first place.7
In contrast to previous findings regarding ED utilization in the OHIE population, returning
insured expenditures were not higher than (and newly insured expenditures were
significantly lower than) continuously insured estimates. Adjusted estimates for both types
of new enrollees, while showing the same relationship to one another, were shifted down in
relation to corresponding cohorts within the OHIE population (with the continuously insured
functioning as a control group, not likely to have changed substantially over this time
period). Individuals who gained Medicaid coverage in 2014 likely had a level of baseline
need lower than that of the 2008 cohort, which had been found to be older and sicker than
the target Oregon Health Plan population.3 The OHIE cohort likely had higher medical
needs than the ACA cohort due to the ACA’s individual insurance mandate.
Patterns for mental and behavioral health, specialist, and primary care seem consistent with
the pent-up demand hypothesis; after a surge in 2014, newly and returning insured
expenditures in these categories fell to a level significantly below the continuously insured.
Interestingly, for all MBH/PC/specialist models, returning insured adjusted estimates
plateaued lower than newly insured, most markedly in the case of specialist care. We
hypothesize that the medical and social complexity leading to coverage instability in the
returning insured may present barriers to managing chronic conditions with regular visits,
leading to more emergency encounters. Average unadjusted monthly costs in all outpatient
categories were greater for returning than newly insured, but their adjusted outpatient
expenditures in 2015 were quite similar (both leveling off about 15% below the continuously
insured), with ED/dental and PC/MBH/specialist differences roughly cancelling out.
Inpatient expenditures, while showing moderate initial increases for returning and newly
insured, did not show strong evidence of an over-time decrease. while absolute costs were
greatest for the continuously insured, all three groups had similar adjusted expenditure
levels, with the newly insured slightly higher than the others at a number of points. Inpatient
costs do not seem to be particularly influenced by insurance coverage history, though
perhaps future studies can explore what services may be driving marginally higher newly
insured levels. It may be that this group has a higher percentage of undiagnosed conditions
requiring hospitalization once diagnosed (e.g., surgeries for cancer discovered after a pastdue screening).
Finally, prescription drug expenditures for the returning and newly insured did not plateau or
decrease with time after the initial surge; rather, they increased over the entire study period,
though at a slower rate after the first seven months. Estimates for the continuously insured,
consistently higher than those for the other groups, also increased. This result aligns with
studies of national Medicaid expenditures that point to increases in medication costs, with
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sharper increases in 2014 than 2015.19–20 Though newly and returning insured prescription
drug expenditures were indistinguishable after the first half of 2014 in the unadjusted model,
newly insured adjusted estimates were greater than those of the returning insured throughout
the study period; this result is consistent with past research that showed individuals with
insurance discontinuities fill their prescriptions less often.8
Our approach lends additional support to the conclusion that the 2014 Medicaid expansion
population had lower average monthly outpatient expenditures than those previously eligible
for Medicaid. Confirming results from an earlier study that used survey data,6 we found that
the healthier population of newly insured individuals had substantially lower unadjusted
monthly expenditures. After adjusting for comorbidity level and other characteristics, we
found that new enrollees were still less costly. Our findings are relevant to policymakers in
states that have implemented Medicaid expansions and those that have not yet expanded
their programs. The data suggest that program evaluators in expansion states should factor
enrollees’ prior insurance histories into their assessment, considering Medicaid expenditures
over at least 24 months to capture initial and long-term expenditure patterns. Policymakers
planning future expansions should prepare for a spike in expenditure from new enrollees, but
can expect demand for services to level off. Further, newly insured expenditures likely
cannot be predicted from utilization patterns of current or ‘churning’ Medicaid enrollees.
Limitations of our study include the inability to completely characterize healthcare costs for
all Medicaid members. Our sample excludes pregnant women and the dual-eligible, both
known to have high expenditures, and we did not have access to claims associated with longterm services and support (LTSS), which includes nursing home care. Despite representing
almost 30% of 2014-2015 Oregon Medicaid expenditures,21 LTSS likely plays a limited role
for the newly enrolled, as utilizers typically have severe health limitations and would have
qualified for Medicaid before the expansion. We excluded emergency and non-emergency
transportation costs, durable medical equipment (DME), visual aids, and hearing devices.
DME, visual aids, and hearing devices are likely to consist largely of one-time expenditures
not appropriate for a time course analysis, and transportation rates are difficult to capture via
standardized expenditures and cannot be generalized to other states.14 Though they were
included in overall outpatient modeling, we did not separately model expenditures for
physical therapists, chiropractors, or other ancillary services. Our repricing algorithm did not
account for changes in reimbursement rates, nor did we factor in additional payments to
providers for meeting quality targets. Despite adjusting for a number of covariates, including
comorbidity, it is likely that we were not able to capture group differences on measures of
more subtle ailments that may drive up healthcare utilization. Importantly, since our data
source was limited to Medicaid claims and enrollment data, we were unable to determine
whether new Medicaid enrollees (newly and returning) had other forms of insurance (e.g.
private insurance) before 2014. Before 2014, however, there were few comprehensive private
coverage options affordable to low-income Americans,22 and recent studies of prior
Medicaid expansions have found the ‘crowd-out’ effect on private insurance to be weaker
than expected.23–24 Although we were unable to determine whether new enrollees had preACA Medicaid coverage in other states, migrants to Oregon from other states represented
only about 3% of the 2014 Oregon population.25 Finally, our study was limited to Oregon
Medicaid enrollees and trends may not extend to states with different social resources.
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Conclusions
Individuals who gained Medicaid in the 2014 expansion in Oregon showed sharp increases
in all outpatient healthcare expenditure categories during the first seven months after the
expansion, followed by either a decrease or plateau for the remainder of the study period.
After initially catching up with continuously insured levels, adjusted outpatient expenditures
for the expansion population (newly and returning insured) were substantially lower than for
the continuously insured by the end of the second year post-ACA. These findings suggest
that, among our subset of relatively healthier Medicaid recipients, continued healthcare
needs were lower among Oregon’s Medicaid expansion population than among the alreadyinsured. Emergency and dental care expenditures among the returning and continuously
insured were similar, with significantly higher expenditures in these two groups compared to
the newly insured even after covariate-adjustment; in contrast, the newly insured utilized
more mental health, specialist, and primary care. The newly insured had higher adjusted
estimates for prescription drugs than the returning insured, while both had lower prescription
drug expenditures than the continuously insured. These findings suggest that the 2014
Medicaid expansion population likely had an initial spike in expenditures from pent-up
demand, but were overall less costly than those already insured by Medicaid. Further,
persistent differences between newly and returning insured expenditures in adjusted models
suggest that insurance history affects the mix of healthcare services that an individual
gaining coverage is likely to need initially and over the long-term. For an accurate
understanding of long-term spending for healthcare services, longitudinal studies should
consider expenditures over at least 24 months. Evaluations of future healthcare policies
should consider enrollees’ prior insurance histories and the over-time stabilization of
expenditures when estimating costs.
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Figure 1.

Outpatient and inpatient unadjusted and adjusted mean monthly expenditure estimates and
95% confidence intervals (shaded region) by insurance cohort

Springer et al.

Page 13

Figure 2.

Emergency, dental, and mental and behavioral health unadjusted and adjusted mean monthly
expenditure estimates and 95% confidence intervals (shaded region) by insurance cohort
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Figure 3.

Primary care (PC) and specialist evaluation, management, and procedures (EM+P), imaging,
and tests unadjusted and adjusted mean monthly expenditure estimates and 95% confidence
intervals (shaded region) by insurance cohort.
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Figure 4.

Total prescription drugs mean monthly expenditure estimates and 95% confidence intervals
(shaded region) by insurance cohort
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